Could Leadership Changes at Ingredion (INGR) Shape the Next Phase of Specialty Segment Strategy?

• Ingredion Incorporated recently appointed Patrick Kalotis as executive vice president, Global Texture & Healthful Solutions, adding him to the executive leadership team with responsibility for the segment's commercial and financial performance.
• Kalotis' extensive background leading growth initiatives at major food and beverage companies positions him to drive strategic business development and innovation within Ingredion's high-value specialty segment.
• We'll now consider how Kalotis' appointment to guide Texture & Healthful Solutions could influence Ingredion's overall investment narrative and future prospects.

Rare earth metals are an input to most high-tech devices, military and defence systems and electric vehicles. The global race is on to secure supply of these critical minerals. Beat the pack to uncover the 36 best rare earth metal stocks of the very few that mine this essential strategic resource.

Ingredion Investment Narrative Recap

Being a shareholder in Ingredion means believing in the company's ability to build on specialty ingredient demand, especially for health and wellness, despite price/mix and foreign exchange headwinds. The appointment of Patrick Kalotis as EVP is a strong leadership addition but is unlikely to materially influence the most important near-term catalyst, which remains the performance of the Texture & Healthful Solutions segment, or the biggest risk, which is the ongoing margin pressure tied to sourcing and raw material costs.

Among recent announcements, Ingredion’s upcoming third-quarter 2025 earnings release stands out as the most immediately relevant, offering investors a closer look at how the Texture & Healthful Solutions segment is trending and how new leadership may position it for future growth. This timing will provide important updates regarding operating income, volume growth, and the ability to sustain segment margin gains in a changing cost environment.

In contrast, while executive changes suggest renewed focus, investors should also be aware that margin levels in the specialty segment...

Read the full narrative on Ingredion (it's free!)

Ingredion's narrative projects $7.8 billion revenue and $696.0 million earnings by 2028. This requires 2.0% yearly revenue growth and a $20 million earnings increase from $676.0 million today.

Uncover how Ingredion's forecasts yield a $146.33 fair value, a 21% upside to its current price.

Exploring Other Perspectives

Simply Wall St Community members produced six fair value estimates for Ingredion ranging from US$119.06 up to US$285.06 per share. With margin risks still present in the Texture & Healthful Solutions unit, it’s clear that expectations for the company’s future can vary dramatically, be sure to compare these viewpoints for a fuller picture.

Explore 6 other fair value estimates on Ingredion - why the stock might be worth just $119.06!

Build Your Own Ingredion Narrative

Disagree with existing narratives? Create your own in under 3 minutes - extraordinary investment returns rarely come from following the herd.

• A great starting point for your Ingredion research is our analysis highlighting 5 key rewards that could impact your investment decision.
• Our free Ingredion research report provides a comprehensive fundamental analysis summarized in a single visual - the Snowflake - making it easy to evaluate Ingredion's overall financial health at a glance.

Ready To Venture Into Other Investment Styles?

Early movers are already taking notice. See the stocks they're targeting before they've flown the coop:

• Trump has pledged to "unleash" American oil and gas and these 22 US stocks have developments that are poised to benefit.
• Find companies with promising cash flow potential yet trading below their fair value.
• Outshine the giants: these 24 early-stage AI stocks could fund your retirement.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com